Epirubicin Hydrochloride 2 mg/ml solution for injection or infusion Irland - engelska - HPRA (Health Products Regulatory Authority)

epirubicin hydrochloride 2 mg/ml solution for injection or infusion

accord healthcare ireland ltd. - epirubicin hydrochloride - solution for injection/infusion - 2 milligram(s)/millilitre - anthracyclines and related substances; epirubicin

Epirubicin Hydrochloride 2 mg/ml solution for injection or infusion Irland - engelska - HPRA (Health Products Regulatory Authority)

epirubicin hydrochloride 2 mg/ml solution for injection or infusion

accord healthcare limited - epirubicin hydrochloride - solution for injection - 2 milligram(s)/millilitre - anthracyclines and related substances; epirubicin

DBL™ Epirubicin Hydrochloride Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

dbl™ epirubicin hydrochloride

pfizer new zealand limited - epirubicin hydrochloride 2 mg/ml;   - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: · breast cancer, · gastric cancer, · ovarian cancer, · small cell lung cancer, · lymphoma (non-hodgkin's lymphoma), · advanced/metastatic soft tissue sarcoma, and · superficial bladder cancer (tis; ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3). epirubicin has also shown antitumour activity in the following tumours: · carcinoma of the oesophagus · primary hepatocellular carcinoma · pancreatic carcinoma · carcinoma of the head and neck · acute leukaemias and multiple myeloma